Caligan Partners LP

Founded in 2017, Caligan Partners is a prominent specialty hedge fund based in New York, led by David Johnson. The fund specializes in long-biased activist equity strategies and occasionally invests in distressed debt and high absolute return opportunities.

Caligan Partners primarily focuses on investment opportunities in the healthcare sector, with its holdings currently concentrated entirely in this industry, accounting for 100% of its portfolio value. The firm engages in both long and short positions, targeting equity opportunities in publicly traded healthcare companies.

David Johnson

David Johnson, Partner and Co-Founder of Caligan Partners LP, previously served as a Managing Director at The Carlyle Group (2010–2017) and Vice President in Principal Investments at Morgan Stanley (2004–2010). He was a director at AMAG Pharmaceuticals (2019–2020) and serves on the boards of the Children's Scholarship Fund and the Harvard College Fund. He holds an A.B. in Applied Mathematics, cum laude, and an S.M. in Applied Mathematics from Harvard College (2004).

Letters

Anika Therapeutics, Inc. - 21-Feb-2023

Companies with fund stakes involved in activist actions such as 13D filing(s) or proxy campaign(s).